Vaginal collagen I and III changes after carbon dioxide laser application in postmenopausal women with the genitourinary syndrome: a pilot study

References

• Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–1068.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause – global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199–215.
   PubMed Web of Science ®Google Scholar
• Sartori DV, Gameiro MO, Kawano PR, et al. Impact of vulvovaginal atrophy on pelvic floor muscle strength in healthy continent women. Int J Urol. 2019;26(1):57–61.
   PubMed Web of Science ®Google Scholar
• Vieira-Baptista P, Marchitelli C, Haefner HK, et al. Deconstructing the genitourinary syndrome of menopause. Int Urogynecol J. 2017;28(5):675–679.
   PubMed Web of Science ®Google Scholar
• DiBonaventura M, Luo X, Moffatt M, et al. The association between vulvovaginal atrophy symptoms and quality of life among postmenopausal women in the United States and Western Europe. J Womens Health. 2015;24(9):713–722.
   PubMed Web of Science ®Google Scholar
• Portman D, Shulman L, Yeaw J, et al. One-year treatment persistence with local estrogen therapy postmenopausal women diagnosed as having vaginal atrophy. Menopause. 2015;22(11):1197–1203.
   PubMed Web of Science ®Google Scholar
• Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;2016(8):CD001500.
   PubMedGoogle Scholar
• Sinha A, Ewies AAA. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric. 2013;16(3):305–312.
   PubMed Web of Science ®Google Scholar
• Gaspar A, Addamo G, Brandi H. Vaginal fractional CO2 laser: a minimally invasive option for vaginal rejuvenation. Am J Cosmet Surg. 2011;28(3):7.
   Google Scholar
• Athanasiou S, Pitsouni E, Antonopoulou S, et al. The effect of microablative fractional CO2 laser on vaginal flora of postmenopausal women. Climacteric. 2016;19(5):512–518.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause. 2017;24(3):316–319.
   PubMed Web of Science ®Google Scholar
• Su CF, Chen GD, Tsai HJ. Preliminary outcome of non-ablative vaginal Erbium laser treatment for female stress and mixed urinary incontinence. Taiwan J Obstet Gynecol. 2019;58(5):610–613.
   PubMed Web of Science ®Google Scholar
• Maris E, Salerno J, Hédon B, et al. Traitements physiques de l’atrophie vulvovaginale. RPC Les femmes ménopausées CNGOF–GEMVi [Management of vulvovaginal atrophy: physical therapies. CNGOF and GEMVi clinical practice guidelines. Gynecol Obstet Fertil Senol. 2021;49(5):414–419.
   PubMedGoogle Scholar
• Preti M, Vieira-Baptista P, Digesu GA, et al. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: an ICS/ISSVD best practice consensus document. J Low Genit Tract Dis. 2019;23(2):151–160.
   PubMed Web of Science ®Google Scholar
• Zerbinati N, Serati M, Origoni M, et al. Microscopic and ultrastructural modifications of postmenopausal atrophic vaginal mucosa after fractional carbon dioxide laser treatment. Lasers Med Sci. 2015;30(1):429–436.
   PubMed Web of Science ®Google Scholar
• González Isaza P, Jaguszewska K, Cardona JL, et al. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J. 2018;29(2):211–215.
   PubMed Web of Science ®Google Scholar
• Cunha R, Bonati Mattos C, Locatelli D, et al. Intravaginal Co2 laser as an emergent treatment of genitourinary syndrome. J Eur Acad Dermatol Venereol. 2019;33(4):e183–e185.
   PubMed Web of Science ®Google Scholar
• Weber MA, Limpens J, Roovers JPWR. Assessment of vaginal atrophy: a review. Int Urogynecol J. 2015;26(1):15–28.
   PubMed Web of Science ®Google Scholar
• Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20.
   PubMed Web of Science ®Google Scholar
• Thiel R, do RC, Dambros M, Palma PCR, et al. [Translation into Portuguese, cross-national adaptation and validation of the Female Sexual Function Index]. Rev Bras Ginecol Obstet. 2008;30(10):504–510.
   PubMedGoogle Scholar
• Dall'Agno ML, Ferreira CF, Ferreira FV, et al. Validation of the six-item female sexual function index in middle-aged Brazilian women. Rev Bras Ginecol Obstet. 2019;41(7):432–439.
   PubMedGoogle Scholar
• Tamanini JTN, Dambros M, D'Ancona CAL, et al. Validação para o português do “International Consultation on Incontinence Questionnaire – Short Form” (ICIQ-SF). Rev Saúde Pública. 2004;38(3):438–444.
   PubMed Web of Science ®Google Scholar
• Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23(4):322–330.
   PubMed Web of Science ®Google Scholar
• Fernández-Alonso AM, Alcaide-Torres J, Fernández-Alonso IM, et al. Application of the 21-item Vulvovaginal Symptoms Questionnaire in postmenopausal Spanish women. Menopause. 2017;24(11):1295–1301.
   PubMed Web of Science ®Google Scholar
• Pieralli A, Fallani MG, Becorpi A, et al. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet. 2016;294(4):841–846.
   PubMed Web of Science ®Google Scholar
• Sokol ER, Karram MM. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Menopause. 2017;24(7):810–814.
   PubMed Web of Science ®Google Scholar
• Politano CA, Costa-Paiva L, Aguiar LB, et al. Fractional CO2 Laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial. Menopause. 2019;26(8):833–840.
   PubMed Web of Science ®Google Scholar
• Pitsouni E, Grigoriadis T, Tsiveleka A, et al. Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas. 2016;94:131–136.
   PubMed Web of Science ®Google Scholar
• Gaspar A, Brandi H, Gomez V, et al. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause: efficacy of erbium:yag laser treatment of GSM. Lasers Surg Med. 2017;49(2):160–168.
   PubMed Web of Science ®Google Scholar
• Borges J, Araújo L, Cuzzi T, et al. Fractional Laser Resurfacing Treats Photoaging by Promoting Neocollegenesis and Cutaneous Edema. J Clin Aesthet Dermatol. 2020;13(1):22–27.
   PubMedGoogle Scholar
• Lattouf R, Younes R, Lutomski D, et al. Picrosirius red staining: a useful tool to appraise collagen networks in normal and pathological tissues. J Histochem Cytochem. 2014;62(10):751–758.
   PubMed Web of Science ®Google Scholar
• Min S, Yoon JY, Park SY, Moon J, et al. Combination of platelet rich plasma in fractional carbon dioxide laser treatment increased clinical efficacy of for acne scar by enhancement of collagen production and modulation of laser-induced inflammation. Lasers Surg Med. 2018;50(4):302–310.
   PubMed Web of Science ®Google Scholar
• Lee S, Suh D-H, Lee JM, et al. Dermal remodeling of burn scar by fractional CO2 laser. Aesthetic Plast Surg. 2016;40(5):761–768.
   PubMed Web of Science ®Google Scholar
• Tawfic SO, El‐Tawdy A, Shalaby S, et al. Evaluation of fractional CO2 versus long pulsed Nd:YAG lasers in treatment of hypertrophic scars and keloids: a randomized clinical trial. Lasers Surg Med. 2020;52(10):959–965.
   PubMed Web of Science ®Google Scholar
• Cañedo-Dorantes L, Cañedo-Ayala M. Skin acute wound healing: a comprehensive review. Int J Inflam. 2019;2019:3706315.
   PubMed Web of Science ®Google Scholar
• Shin JU, Roh MR, Rah DK, et al. The effect of succinylated atelocollagen and ablative fractional resurfacing Laser on striae distensae. J Dermatolog Treat. 2011;22(2):113–121.
   PubMed Web of Science ®Google Scholar
• Kwon T-R, Kim JH, Seok J, et al. Fractional CO2 laser treatment for vaginal laxity: a preclinical study. Lasers Surg Med. 2018;50(9):940–947. Nov
   PubMed Web of Science ®Google Scholar
• Natari S, Kim KE, Ryu SI, et al. Device-induced neocollagenesis: profibrotic response or true neocollagenesis? Lasers Surg Med. 2020;52(10):1010–1019.
   PubMed Web of Science ®Google Scholar
• Falconer C, Ekman-Ordeberg G, Ulmsten U, et al. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas. 1996;24(3):197–204.
   PubMed Web of Science ®Google Scholar
• Gaspar A, Silva J, Calderon A, et al. Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy. Climacteric. 2020;23(sup1):S11–S13.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Torelli MG, Martella L, et al. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Climacteric. 2015;18(sup1):43–48.
   PubMed Web of Science ®Google Scholar
• Sokol ER, Karram MM. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy. Menopause. 2016;23(10):1102–1107.
   PubMed Web of Science ®Google Scholar
• Gordon C, Gonzales S, Krychman ML. Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy. Menopause. 2019;26(4):423–427.
   PubMed Web of Science ®Google Scholar
• Mackova K, Mazzer AM, Mori Da Cunha M, et al. Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial. BJOG. 2021;128(6):1087–1096.
   PubMedGoogle Scholar